OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00068359

Inner Mongolia Berun Chemical Co Ltd

Commodity ChemicalsVerified

The company's capital structure is characterized by a debt-to-equity ratio of 0.99, indicating a relatively balanced mix of debt and equity financing. However, the current ratio of 0.28 suggests a significant liquidity risk, as the company's current assets are insufficient to cover its short-term liabilities. The negative free cash flow of -1.65 billion CNY and a capital expenditure of -3.38 billion CNY indicate that the company is investing heavily in its operations, which may be a strategic move to expand or modernize its facilities. In terms of profitability, the company's return on equity of 7.5% and return on assets of 2.5% are below the industry median for Commodity Chemicals, suggesting that the company is not generating returns as efficiently as its peers. The net income of 942.17 million CNY and operating income of 2.01 billion CNY reflect a solid performance, but the gross profit margin of 29.4% is a key area to monitor for sustainability. The company's revenue is primarily concentrated in its core chemical manufacturing operations, with no significant diversification into other segments. Geographically, the company's exposure is largely domestic, with no disclosed international operations. This concentration may pose a risk if domestic demand for commodity chemicals declines or if regulatory changes impact the industry. The company's growth trajectory is mixed. While the current fiscal year is expected to show a modest increase in revenue, the next fiscal year is projected to see a decline. This suggests that the company may be facing headwinds in the near term, possibly due to market saturation or increased competition. The capital expenditure of -3.38 billion CNY indicates a commitment to long-term growth, but the negative free cash flow raises concerns about the company's ability to sustain such investments without external financing. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could limit its ability to respond to unexpected financial needs. However, the low dilution risk suggests that the company is not likely to issue additional shares in the near term, which is a positive sign for existing shareholders. Recent events, as reflected in the financial data, show a consistent pattern of revenue and profit generation. The company's operating cash flow of 2.56 billion CNY is a positive indicator, but the negative free cash flow and high capital expenditure suggest that the company is reinvesting heavily in its operations. Analysts have provided a mean price target of 10.50 CNY, with a mean recommendation of 1.50, indicating a generally positive outlook despite the current financial challenges.

30-day price · 000683-0.19 (-2.3%)
Low$8.18High$9.29Close$8.22As of15 May, 00:00 UTC
Profile
CompanyInner Mongolia Berun Chemical Co Ltd
Ticker000683.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Inner Mongolia Berun Chemical Co Ltd produces and sells commodity chemicals, primarily generating revenue through the manufacturing and distribution of chemical products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

The company's capital structure is characterized by a debt-to-equity ratio of 0.99, indicating a relatively balanced mix of debt and equity financing. However, the current ratio of 0.28 suggests a significant liquidity risk, as the company's current assets are insufficient to cover its short-term liabilities. The negative free cash flow of -1.65 billion CNY and a capital expenditure of -3.38 billion CNY indicate that the company is investing heavily in its operations, which may be a strategic move to expand or modernize its facilities. In terms of profitability, the company's return on equity of 7.5% and return on assets of 2.5% are below the industry median for Commodity Chemicals, suggesting that the company is not generating returns as efficiently as its peers. The net income of 942.17 million CNY and operating income of 2.01 billion CNY reflect a solid performance, but the gross profit margin of 29.4% is a key area to monitor for sustainability. The company's revenue is primarily concentrated in its core chemical manufacturing operations, with no significant diversification into other segments. Geographically, the company's exposure is largely domestic, with no disclosed international operations. This concentration may pose a risk if domestic demand for commodity chemicals declines or if regulatory changes impact the industry. The company's growth trajectory is mixed. While the current fiscal year is expected to show a modest increase in revenue, the next fiscal year is projected to see a decline. This suggests that the company may be facing headwinds in the near term, possibly due to market saturation or increased competition. The capital expenditure of -3.38 billion CNY indicates a commitment to long-term growth, but the negative free cash flow raises concerns about the company's ability to sustain such investments without external financing. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could limit its ability to respond to unexpected financial needs. However, the low dilution risk suggests that the company is not likely to issue additional shares in the near term, which is a positive sign for existing shareholders. Recent events, as reflected in the financial data, show a consistent pattern of revenue and profit generation. The company's operating cash flow of 2.56 billion CNY is a positive indicator, but the negative free cash flow and high capital expenditure suggest that the company is reinvesting heavily in its operations. Analysts have provided a mean price target of 10.50 CNY, with a mean recommendation of 1.50, indicating a generally positive outlook despite the current financial challenges.
Key takeaways
  • The company has a balanced debt-to-equity ratio but faces liquidity risks due to a low current ratio.
  • Profitability metrics are below industry medians, indicating inefficiencies in generating returns.
  • Revenue is concentrated in a single segment with no international diversification.
  • Growth is expected to slow in the next fiscal year, with significant capital expenditures.
  • Analysts have a generally positive outlook, but liquidity and free cash flow concerns persist.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$12.07B
Gross profit$3.55B
Operating income$2.01B
Net income$942.2M
R&D
SG&A
D&A
SBC
Operating cash flow$2.56B
CapEx-$3.38B
Free cash flow-$1.65B
Total assets$37.62B
Total liabilities$25.06B
Total equity$12.56B
Cash & equivalents
Long-term debt$12.47B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$12.07B$2.01B$942.2M-$1.65B
FY-1$13.26B$3.60B$1.81B$1.71B
FY-2$12.04B$3.67B$1.41B-$1.30B
FY-3$10.99B$3.66B$2.66B$174.6M
FY-4$12.15B$6.35B$4.95B$5.82B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$37.62B$12.56B
FY-1$35.88B$14.50B
FY-2$34.09B$13.49B
FY-3$29.86B$12.53B
FY-4$26.07B$11.65B$4.87B
PeriodOCFCapExFCFSBC
FY0$2.56B-$3.38B-$1.65B
FY-1$4.51B-$1.34B$1.71B
FY-2$3.14B-$3.68B-$1.30B
FY-3$3.25B-$3.27B$174.6M
FY-4$3.49B-$774.4M$5.82B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$2.72B$635.8M$420.1M
FQ-1$3.42B$166.0M-$119.8M
FQ-2$2.74B$548.9M$319.3M
FQ-3$3.05B$720.1M$403.5M
FQ-4$2.87B$571.3M$339.2M
FQ-5$2.89B$470.7M$6.6M
FQ-6$3.30B$946.1M$595.5M
FQ-7$3.79B$1.18B$640.0M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$39.61B$13.02B$1.51B
FQ-1$37.62B$12.56B
FQ-2$39.31B$14.54B$3.84B
FQ-3$38.32B$14.22B
FQ-4$36.53B$14.89B$3.50B
FQ-5$35.88B$14.50B
FQ-6$34.63B$14.44B$2.96B
FQ-7$33.05B$13.79B
PeriodOCFCapExFCFSBC
FQ0$574.3M-$932.8M
FQ-1$2.56B-$3.38B
FQ-2$2.97B-$1.85B
FQ-3$1.26B-$676.2M
FQ-4$799.3M-$368.8M
FQ-5$4.51B-$1.34B
FQ-6$3.00B-$1.02B
FQ-7$1.36B-$528.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$12.56B
Net cash-$12.47B
Current ratio0.3
Debt/Equity1.0
ROA2.5%
ROE7.5%
Cash conversion2.7%
CapEx/Revenue-28.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000683Activity
Op margin16.7%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin7.8%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin29.4%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-28.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity99.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target10.50 CNY
Median price target10.50 CNY
High price target10.50 CNY
Low price target10.50 CNY
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.53 CNY
Last actual EPS0.25 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 03:13 UTCJob: fc0045ca